

![]() |
The risk of placental abruption when using prostaglandins for cervical ripening in women with preeclampsia: comparing misoprostol versus dinoprostone |
|
Authors | ||
Published in | Journal of maternal-fetal & neonatal medicine. 2010, vol. 23, no. 9, p. 988-93 | |
Abstract | Recent data have raised concern about the safety of using misoprostol in women with preeclampsia. We wanted to evaluate the risk of placental abruption in women with preeclampsia undergoing cervical ripening with misoprostol compared to dinoprostone. | |
Keywords | Abruptio Placentae/epidemiology/etiology — Administration, Intravaginal — Adolescent — Adult — Cervical Ripening/drug effects — Dinoprostone/administration & dosage/adverse effects — Female — Humans — Incidence — Labor, Induced/methods — Middle Aged — Misoprostol/administration & dosage/adverse effects — Oxytocics/administration & dosage/adverse effects — Pre-Eclampsia/epidemiology/therapy — Pregnancy — Prostaglandins/administration & dosage/adverse effects — Risk — Young Adult | |
Identifiers | PMID: 19941444 | |
Full text | ||
Structures | ||
Research group | Martinez De Tejada Begona (272) | |
Citation (ISO format) | MARTINEZ DE TEJADA WEBER, Begona et al. The risk of placental abruption when using prostaglandins for cervical ripening in women with preeclampsia: comparing misoprostol versus dinoprostone. In: Journal of maternal-fetal & neonatal medicine, 2010, vol. 23, n° 9, p. 988-93. doi: 10.3109/14767050903443475 https://archive-ouverte.unige.ch/unige:21446 |